Clinical characteristics of bone disease in multiple myeloma and clinical significance of monitoring bone metabolic markers

被引：1
|
作者：
褚彬 [1 ]
机构：
[1] Dept Hematol, Beijing Jishuitan Hosp
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2016年 / 33卷 / 03期
关键词：
bone; CTX; PINP;
D O I：
暂无
中图分类号：
R733.3 [骨髓肿瘤];
学科分类号：
摘要：
Objective To observe the clinical characteristics of bone disease in patients with multiple myeloma(MM)and the clinical significance of monitoring bone metabolic markers.Methods The data of 178 MM case newly diagnosed in Beijing Ji Shui Tan Hospital from January 2009to June 2014 were reviewed to analyze the types and classification of bone disease and to observe the clinical char-
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [41] Clinical significance of interleukin-6 gene expression in the bone marrow of patients with multiple myeloma
    Iwasaki, T
    Hamano, T
    Ogata, A
    Kakishita, E
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 70 (03) : 163 - 168
  • [42] The clinical impact of metabolic bone disease in coeliac disease
    Fickling, WE
    McFarlane, XA
    Bhalla, AK
    Robertson, DAF
    POSTGRADUATE MEDICAL JOURNAL, 2001, 77 (903) : 33 - 36
  • [43] Bone Turnover Biomarkers Are Useful In Monitoring Myeloma Bone Disease and As Early Predictor Biomarkers For Relapse Disease In Multiple Myeloma
    Ting, Kay Reen
    Hameed, Abdul
    Brady, Jennifer
    Dowling, Paul
    Clarke, Colin
    Meiller, Justine
    Mitsiades, Constantine S.
    Richardson, Paul G.
    Anderson, Kenneth C.
    Clynes, Martin
    O'Gorman, Peter
    BLOOD, 2013, 122 (21)
  • [44] Myeloma bone disease: Pathogenetic mechanisms and clinical assessment
    Silvestris, Franco
    Lombardi, Lucia
    De Matteo, Monica
    Bruno, Arianna
    Dammacco, Franco
    LEUKEMIA RESEARCH, 2007, 31 (02) : 129 - 138
  • [45] Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management
    Kristinsson, Sigurdur Y.
    Minter, Alex R.
    Korde, Neha
    Tan, Esther
    Landgren, Ola
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2011, 11 (06) : 593 - 603
  • [46] CLINICAL INVESTIGATION IN METABOLIC BONE DISEASE - QUANTITATIVE MEASUREMENTS OF BONE MINERAL
    EVENS, RG
    PAK, CYC
    ASHBURN, W
    BARTTER, FC
    INVESTIGATIVE RADIOLOGY, 1969, 4 (06) : 364 - +
  • [47] CLINICAL-SIGNIFICANCE OF FREE PLASMA HYDROXYPROLINE MEASUREMENT IN METABOLIC BONE-DISEASE
    MINISOLA, S
    ANTONELLI, R
    MAZZUOLI, G
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1985, 23 (09): : 515 - 519
  • [48] GENE EXPRESSION OF BONE MODULATORS IN WHOLE BONE MARROW BIOPSIES IN CORRELATION TO DYNAMIC BONE MARKERS IN MULTIPLE MYELOMA BONE DISEASE
    Kristensen, I.
    Christensen, J.
    Lyng, M.
    Ditzel, H.
    Abildgaard, N.
    HAEMATOLOGICA, 2013, 98 : 318 - 318
  • [49] URINARY HYDROXYPROLINE IN MULTIPLE-MYELOMA - CORRELATION WITH CLINICAL STAGES AND BONE-DISEASE
    BOLZONELLA, S
    PACCAGNELLA, A
    SALVAGNO, L
    SILENI, VC
    DEBESI, P
    SCALELLA, P
    FIORENTINO, MV
    TUMORI JOURNAL, 1984, 70 (03): : 249 - 253
  • [50] NEW BIOLOGICAL MARKERS OF BONE TURNOVER FOR THE CLINICAL INVESTIGATION OF METABOLIC BONE-DISEASES
    DELMAS, P
    ANNALES DE BIOLOGIE CLINIQUE, 1988, 46 (07) : 491 - 491
12345